Diagnosis | MTX | PHT | GOL | ETA | ADA | CER | ABA | SECU | Total |
---|---|---|---|---|---|---|---|---|---|
MA/SD | |||||||||
Rheumatoid arthirits | 30 | 0 | 2 | 4 | 2 | 1 | 2 | 0 | 41 |
62±16 | |||||||||
Psoriatic arthritis | 9 | 0 | 5 | 1 | 1 | 1 | 0 | 1 | 18 |
52±17 | |||||||||
Anquilosing spondilytis | 1 | 0 | 2 | 2 | 3 | 2 | 0 | 0 | 10 |
48±12 | |||||||||
Osteoporosi | 0 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 40 |
79±7 | |||||||||
Total (%) | 40 (37%) | 40 (37%) | 9 (8%) | 7 (6%) | 6 (6%) | 4 (3%) | 2 (2%) | 1 (1%) | 109 |
MTX: methotrexate PTH: teriparatide GOL: golimumab ETA: etanercept ADA: adalimumab CER: certolizumab ABA: abatacept SECU: secukimumab SD: standard deviation.